Can leukemic stem cells predict short-term outcome in acute myeloid leukemia? – A prospective cohort study from India
Journal of Laboratory Physicians · 04.08.2026 · 18 · 405-414
DOI: 10.25259/jlp_385_2025 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Laboratory Physicians, online erschienen am 04.08.2026. Verfasst von Visaali Sivakumar und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objectives: Acute myeloid leukemia (AML) is a clonal stem cell disorder with impaired differentiation, myeloblast proliferation, and genetic heterogeneity. Although remission is frequently achieved with induction therapy, relapse remains common, partly attributed to therapy-resistant leukemic stem cells (LSCs). Indian data on the prognostic significance of LSCs are limited. This study aimed to quantify LSCs at diagnosis using multicolor flow cytometry (MFC) and evaluate their association with clinico-hematological features and response to induction therapy. Materials and Methods: This prospective cohort study (September 2022–January 2024) included newly diagnosed AML patients aged
Zitieren
APA
Sivakumar, V., Manivannan, P., & Kayal, S. (2026). Can leukemic stem cells predict short-term outcome in acute myeloid leukemia? – A prospective cohort study from India. Journal of Laboratory Physicians, 18, 405-414. https://doi.org/10.25259/jlp_385_2025
Vancouver
Sivakumar V, Manivannan P, Kayal S. Can leukemic stem cells predict short-term outcome in acute myeloid leukemia? – A prospective cohort study from India. Journal of Laboratory Physicians. 2026;18:405-414. doi:10.25259/jlp_385_2025
BibTeX
@article{Sivakumar2026,
author = {Sivakumar, Visaali and Manivannan, Prabhu and Kayal, Smita},
title = {Can leukemic stem cells predict short-term outcome in acute myeloid leukemia? – A prospective cohort study from India},
journal = {Journal of Laboratory Physicians},
year = {2026},
volume = {18},
pages = {405--414},
doi = {10.25259/jlp_385_2025}
}
EUVIMED